Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)
72.88
-0.72 (-0.98%)
Jul 21, 2026, 3:00 PM CST
Shanghai Haoyuan Chemexpress Company Description
Shanghai Haoyuan Chemexpress Co., Ltd. engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs.
It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds.
The company was founded in 2006 and is headquartered in Shanghai, China.
Shanghai Haoyuan Chemexpress Co., Ltd.
| Country | China |
| Founded | 2006 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4,195 |
| CEO | Baofu Zheng |
Contact Details
Address: No. 3 Building Shanghai, 201203 China | |
| Phone | 86 21 5899 8590 |
| Website | chemexpress.cn |
Stock Details
| Ticker Symbol | 688131 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000051J4 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Baofu Zheng | Chairman and GM |
| Min Li | Chief Financial Officer and Accounting Supervisor |
| Qiang Gao | Deputy GM and Director |
| Weihong Shen | Board Secretary |
| Zhiguo Zhou | Core Technical Staff |
| Kuei Mei | Core Technical Staff |